Annual Cash & Cash Equivalents
$5.99 M
-$13.45 M-69.19%
December 31, 2023
Summary
- As of February 10, 2025, MACK annual cash & cash equivalents is $5.99 million, with the most recent change of -$13.45 million (-69.19%) on December 31, 2023.
- During the last 3 years, MACK annual cash & cash equivalents has fallen by -$8.05 million (-57.34%).
Performance
MACK Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$234.16 M
+$228.17 M+3809.83%
March 1, 2024
Summary
- As of February 10, 2025, MACK quarterly cash and cash equivalents is $234.16 million, with the most recent change of +$228.17 million (+3809.83%) on March 1, 2024.
- Over the past year, MACK quarterly cash and cash equivalents has increased by +$228.08 million (+3749.42%).
Performance
MACK Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MACK Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.2% | +3749.4% |
| 3 y3 years | -57.3% | +3749.4% |
| 5 y5 years | -70.2% | +3749.4% |
MACK Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -69.2% | at low | at high | -97.4% |
| 5 y | 5-year | -69.2% | at low | at high | -97.4% |
| alltime | all time | -96.8% | at low | at high | -97.4% |
Merrimack Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $234.16 M(+3809.8%) |
| Dec 2023 | $5.99 M(-69.2%) | $5.99 M(-1.5%) |
| Sep 2023 | - | $6.08 M(-40.0%) |
| Jun 2023 | - | $10.13 M(-47.8%) |
| Mar 2023 | - | $19.40 M(-0.2%) |
| Dec 2022 | $19.44 M(+36.9%) | $19.44 M(+48.5%) |
| Sep 2022 | - | $13.09 M(-2.0%) |
| Jun 2022 | - | $13.36 M(-6.6%) |
| Mar 2022 | - | $14.29 M(+0.6%) |
| Dec 2021 | $14.20 M(+1.2%) | $14.20 M(-2.4%) |
| Sep 2021 | - | $14.56 M(-2.4%) |
| Jun 2021 | - | $14.91 M(+7.3%) |
| Mar 2021 | - | $13.89 M(-1.1%) |
| Dec 2020 | $14.04 M(-15.3%) | $14.04 M(-11.2%) |
| Sep 2020 | - | $15.81 M(+0.5%) |
| Jun 2020 | - | $15.73 M(-12.7%) |
| Mar 2020 | - | $18.02 M(+8.7%) |
| Dec 2019 | $16.58 M(-17.4%) | $16.58 M(-20.5%) |
| Sep 2019 | - | $20.86 M(-43.5%) |
| Jun 2019 | - | $36.92 M(+1.0%) |
| Mar 2019 | - | $36.54 M(+82.0%) |
| Dec 2018 | $20.08 M(-78.5%) | $20.08 M(-59.7%) |
| Sep 2018 | - | $49.79 M(+121.7%) |
| Jun 2018 | - | $22.46 M(-34.5%) |
| Mar 2018 | - | $34.27 M(-63.3%) |
| Dec 2017 | $93.44 M | $93.44 M(-12.9%) |
| Sep 2017 | - | $107.25 M(-20.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $135.50 M(+689.9%) |
| Mar 2017 | - | $17.16 M(-20.3%) |
| Dec 2016 | $21.52 M(-88.4%) | $21.52 M(-41.0%) |
| Sep 2016 | - | $36.46 M(+69.7%) |
| Jun 2016 | - | $21.49 M(-55.4%) |
| Mar 2016 | - | $48.24 M(-74.0%) |
| Dec 2015 | $185.61 M(+420.1%) | $185.61 M(+229.4%) |
| Sep 2015 | - | $56.35 M(+67.4%) |
| Jun 2015 | - | $33.66 M(+16.8%) |
| Mar 2015 | - | $28.83 M(-19.2%) |
| Dec 2014 | $35.69 M(-45.2%) | $35.69 M(-64.4%) |
| Sep 2014 | - | $100.32 M(+29.0%) |
| Jun 2014 | - | $77.75 M(+16.2%) |
| Mar 2014 | - | $66.90 M(+2.8%) |
| Dec 2013 | $65.09 M(+72.6%) | $65.09 M(-38.3%) |
| Sep 2013 | - | $105.45 M(+240.8%) |
| Jun 2013 | - | $30.94 M(+8.8%) |
| Mar 2013 | - | $28.43 M(-24.6%) |
| Dec 2012 | $37.71 M(-25.3%) | $37.71 M(+35.1%) |
| Sep 2012 | - | $27.91 M(-12.9%) |
| Jun 2012 | - | $32.04 M(+4.9%) |
| Mar 2012 | - | $30.55 M(-39.4%) |
| Dec 2011 | $50.45 M(+64.3%) | $50.45 M(-14.8%) |
| Sep 2011 | - | $59.23 M(-21.7%) |
| Jun 2011 | - | $75.64 M(+132.0%) |
| Mar 2011 | - | $32.59 M(+6.1%) |
| Dec 2010 | $30.71 M(-47.4%) | $30.71 M |
| Dec 2009 | $58.39 M | - |
FAQ
- What is Merrimack Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Merrimack Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Merrimack Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of MACK is $5.99 M
What is the all time high annual cash & cash equivalents for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual cash & cash equivalents is $185.61 M
What is Merrimack Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, MACK annual cash & cash equivalents has changed by -$13.45 M (-69.19%)
What is Merrimack Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MACK is $234.16 M
What is the all time high quarterly cash and cash equivalents for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly cash and cash equivalents is $234.16 M
What is Merrimack Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, MACK quarterly cash and cash equivalents has changed by +$228.08 M (+3749.42%)